Pharmaceutical composition for preventing/treating respiratory system disease and use of pharmaceutical composition
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for respiratory diseases, composition, applied in the field of medicine
Active Publication Date: 2014-12-03
天津中医药大学第二附属医院
View PDF1 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, there is currently no clinically available Chinese patent medicine specifically for the treatment of pulmonary fibrosis, so it is of great significance to develop drugs that can be used to treat and / or delay the progression of this disease
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0072] Embodiment 1, the preparation of pharmaceutical composition
[0073] Accurately weigh 3000g of astragalus, 2000g of angelica, 1600g of zedoary, 2000g of dogwood, 2000g of aster, 1600g of scutellaria baicalensis, 1000g of zhebei, 1000g of licorice, eight herbs, add water and decoct twice, 2 hours each time, 10 times the amount of water for the first time , the second time 8 times the amount of water, filter, combine the filtrate and concentrate to a clear paste with a relative density of 1.30-1.32 (55°C), dry (drying temperature is 60°C), pulverize into fine powder, and sieve to obtain the composition of the present invention , called "Qizhu Granules" (indicated by the code "QZKL", the same below), 5120g, batch number: QZKL-1.
Embodiment 2
[0074] Embodiment 2, the preparation of pharmaceutical composition
[0075] Accurately weigh 280g of astragalus, 180g of angelica, 180g of zedoary, 180g of dogwood, 220g of aster, 140g of scutellaria baicalensis, 80g of zhebei, 80g of licorice, and eight herbs. , the second time 8 times the amount of water, filter, combine the filtrate and concentrate to a clear paste with a relative density of 1.30-1.32 (55°C), dry (drying temperature is 60°C), pulverize into fine powder, and sieve to obtain the pharmaceutical combination of the present invention Deqizhu Granules 518g, batch number: QZKL-2.
Embodiment 3
[0076] Embodiment 3, the preparation of pharmaceutical composition
[0077] Accurately weigh 320g of astragalus, 220g of angelica, 180g of zedoary, 220g of dogwood, 180g of aster, 140g of scutellaria baicalensis, 100g of zhebei, 80g of licorice, and eight herbs. , the second time 8 times the amount of water, filter, combine the filtrate and concentrate to a clear paste with a relative density of 1.30-1.32 (55°C), dry (drying temperature is 60°C), pulverize into fine powder, and sieve to obtain Qizhu granules 540g, batch number: QZKL-3.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a traditional Chinese medicine composition, a pharmaceutical composition as well as a preparation method thereof and a use of the traditional Chinese medicine composition and the pharmaceutical composition. The preparation materials of active ingredients of the pharmaceutical composition include the following materials in parts by weight: 28-32 parts of astragalus mongholicus and at least one of codonopsis pilosula, ginseng, radix pseudostellariae and American ginseng, 18-22 parts of Chinese angelica and at least one of prepared rehmannia root and dried rehamnnia root, 18-22 parts of dogwood and at least one of polygonum multiflorum, schisandra chinensis, placenta hominis and gecko, 14-18 parts of curcuma zedoary and at least one of rhizoma sparganii, root of red-rooted salvia and red flower, 14-18 parts of scutellaria baicalensis and at least one of polygonum cuspidatum and rhizoma anemarrhenae, 18-22 parts of radix asteris and at least one of radix stemonae and flos farfarae, 8-12 parts of fritillaria thunbergii and 8-12 parts of liquorices.
Description
technical field [0001] The invention relates to the technical field of medicine, in particular to a pharmaceutical composition for treating respiratory diseases, especially pulmonary fibrosis and its application. Background technique [0002] Respiratory diseases are a major disease that endangers human and animal health. Among them, diffuse interstitial lung disease (interstitial lung disease, ILD) is a large group of diseases characterized by chronic inflammation of diffuse alveolar units and interstitial fibrosis, also known as diffuse parenchymal lung disease (diffuse parenchymal lung disease). parenchymal lung disease, DPLD). This type of disease manifests as progressive exertional shortness of breath, restrictive ventilatory dysfunction with diffusion dysfunction, hypoxemia, and diffuse lesions in both lungs on imaging. As the disease progresses, alveolar-capillary functional units are gradually lost, and eventually diffuse pulmonary fibrosis and honeycombing develop...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more